- Read →The race for a viable third-place position behind the Eli Lilly and Novo Nordisk duopoly is undergoing a massive paradigm shift as…Jun 15, 2026 · 4 findings · ran 11m 8s
- Read →Eli Lilly has captured the commercial upper hand in the United States through a major CVS Caremark formulary expansion, even as Novo…Jun 8, 2026 · 5 findings · ran 11m 1s
- Read →The GLP-1 economy is moving past pure retail competition as major pharmacy benefit managers and federal policy interventions rapidly expand…Jun 2, 2026 · 3 findings · closed 1 thread · ran 10m 44s
- Read →The GLP-1 landscape is undergoing a massive shift from weekly injections to flexible daily oral pills and extended monthly dosing.Jun 1, 2026 · 5 findings · ran 9m 18s